Meeting highlights: The second consensus conference for breast cancer treatment in Korea

Seeyoun Lee, In Hae Park, Seho Park, Joohyuk Sohn, Jeong Joon, Sung Gwe Ahn, Ik Jae Lee, Hae Kyung Lee, Seung Ah Lee, Won Park, Kyung Hun Lee, Sung Won Kim, Sang Ah Han, Kyung Hae Jung, Byung Ho Son

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The Korean clinical practice guideline recently developed by the Korean Breast Cancer Society to address the national clinical situation is currently under revision ahead of a seventh recommendation. A second consensus conference was held to further develop this guideline by soliciting opinions regarding important issues related to surgery, radiotherapy, and medical oncology. Several issues were discussed, and the discussion progressed to pros and cons in the context of cases in various clinical situations. The panels discussed and voted on issues regarding surgical treatment for non-axillary regional lymph nodes, regional nodal irradiation of pN1 disease, and ovarian functional suppression (OFS) as an adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer. Regarding the surgical treatment of non-axillary regional lymph node, most panelists agreed with the recommendation of preoperative che- motherapy and postoperative radiotherapy for patients with biopsy-diagnosed metastases, whereas surgery or radiotherapy of non-axillary regional lymph nodes was suggested for clinical partial responders. Discussions on radiotherapy addressed the need for adjuvant radiotherapy and radiation field of regional lymph node in the context of various N1 breast cancer cases. The participants reached a consensus to recommend that N1 patients should receive regional nodal irradiation for a large tumor burden (e.g., three positive nodes, perinodal extension, or large primary tumor). Finally, the panels favored OFS in addition to endocrine therapy for premenopausal women with high risk factors such as a large tumor size, involvement of more than three nodes, and a high histologic grade.

Original languageEnglish
Pages (from-to)228-233
Number of pages6
JournalJournal of Breast Cancer
Volume20
Issue number3
DOIs
Publication statusPublished - 2017 Sep 1

Fingerprint

Korea
Radiotherapy
Lymph Nodes
Breast Neoplasms
Ovarian Diseases
Adjuvant Radiotherapy
Medical Oncology
Therapeutics
Tumor Burden
Practice Guidelines
Neoplasms
Hormones
Guidelines
Radiation
Neoplasm Metastasis
Biopsy
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Lee, Seeyoun ; Park, In Hae ; Park, Seho ; Sohn, Joohyuk ; Joon, Jeong ; Ahn, Sung Gwe ; Lee, Ik Jae ; Lee, Hae Kyung ; Lee, Seung Ah ; Park, Won ; Lee, Kyung Hun ; Kim, Sung Won ; Han, Sang Ah ; Jung, Kyung Hae ; Son, Byung Ho. / Meeting highlights : The second consensus conference for breast cancer treatment in Korea. In: Journal of Breast Cancer. 2017 ; Vol. 20, No. 3. pp. 228-233.
@article{f02f0d8b6d45456fb1ade70ce297ef11,
title = "Meeting highlights: The second consensus conference for breast cancer treatment in Korea",
abstract = "The Korean clinical practice guideline recently developed by the Korean Breast Cancer Society to address the national clinical situation is currently under revision ahead of a seventh recommendation. A second consensus conference was held to further develop this guideline by soliciting opinions regarding important issues related to surgery, radiotherapy, and medical oncology. Several issues were discussed, and the discussion progressed to pros and cons in the context of cases in various clinical situations. The panels discussed and voted on issues regarding surgical treatment for non-axillary regional lymph nodes, regional nodal irradiation of pN1 disease, and ovarian functional suppression (OFS) as an adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer. Regarding the surgical treatment of non-axillary regional lymph node, most panelists agreed with the recommendation of preoperative che- motherapy and postoperative radiotherapy for patients with biopsy-diagnosed metastases, whereas surgery or radiotherapy of non-axillary regional lymph nodes was suggested for clinical partial responders. Discussions on radiotherapy addressed the need for adjuvant radiotherapy and radiation field of regional lymph node in the context of various N1 breast cancer cases. The participants reached a consensus to recommend that N1 patients should receive regional nodal irradiation for a large tumor burden (e.g., three positive nodes, perinodal extension, or large primary tumor). Finally, the panels favored OFS in addition to endocrine therapy for premenopausal women with high risk factors such as a large tumor size, involvement of more than three nodes, and a high histologic grade.",
author = "Seeyoun Lee and Park, {In Hae} and Seho Park and Joohyuk Sohn and Jeong Joon and Ahn, {Sung Gwe} and Lee, {Ik Jae} and Lee, {Hae Kyung} and Lee, {Seung Ah} and Won Park and Lee, {Kyung Hun} and Kim, {Sung Won} and Han, {Sang Ah} and Jung, {Kyung Hae} and Son, {Byung Ho}",
year = "2017",
month = "9",
day = "1",
doi = "10.4048/jbc.2017.20.3.228",
language = "English",
volume = "20",
pages = "228--233",
journal = "Journal of Breast Cancer",
issn = "1738-6756",
publisher = "Korean Breast Cancer Society",
number = "3",

}

Lee, S, Park, IH, Park, S, Sohn, J, Joon, J, Ahn, SG, Lee, IJ, Lee, HK, Lee, SA, Park, W, Lee, KH, Kim, SW, Han, SA, Jung, KH & Son, BH 2017, 'Meeting highlights: The second consensus conference for breast cancer treatment in Korea', Journal of Breast Cancer, vol. 20, no. 3, pp. 228-233. https://doi.org/10.4048/jbc.2017.20.3.228

Meeting highlights : The second consensus conference for breast cancer treatment in Korea. / Lee, Seeyoun; Park, In Hae; Park, Seho; Sohn, Joohyuk; Joon, Jeong; Ahn, Sung Gwe; Lee, Ik Jae; Lee, Hae Kyung; Lee, Seung Ah; Park, Won; Lee, Kyung Hun; Kim, Sung Won; Han, Sang Ah; Jung, Kyung Hae; Son, Byung Ho.

In: Journal of Breast Cancer, Vol. 20, No. 3, 01.09.2017, p. 228-233.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Meeting highlights

T2 - The second consensus conference for breast cancer treatment in Korea

AU - Lee, Seeyoun

AU - Park, In Hae

AU - Park, Seho

AU - Sohn, Joohyuk

AU - Joon, Jeong

AU - Ahn, Sung Gwe

AU - Lee, Ik Jae

AU - Lee, Hae Kyung

AU - Lee, Seung Ah

AU - Park, Won

AU - Lee, Kyung Hun

AU - Kim, Sung Won

AU - Han, Sang Ah

AU - Jung, Kyung Hae

AU - Son, Byung Ho

PY - 2017/9/1

Y1 - 2017/9/1

N2 - The Korean clinical practice guideline recently developed by the Korean Breast Cancer Society to address the national clinical situation is currently under revision ahead of a seventh recommendation. A second consensus conference was held to further develop this guideline by soliciting opinions regarding important issues related to surgery, radiotherapy, and medical oncology. Several issues were discussed, and the discussion progressed to pros and cons in the context of cases in various clinical situations. The panels discussed and voted on issues regarding surgical treatment for non-axillary regional lymph nodes, regional nodal irradiation of pN1 disease, and ovarian functional suppression (OFS) as an adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer. Regarding the surgical treatment of non-axillary regional lymph node, most panelists agreed with the recommendation of preoperative che- motherapy and postoperative radiotherapy for patients with biopsy-diagnosed metastases, whereas surgery or radiotherapy of non-axillary regional lymph nodes was suggested for clinical partial responders. Discussions on radiotherapy addressed the need for adjuvant radiotherapy and radiation field of regional lymph node in the context of various N1 breast cancer cases. The participants reached a consensus to recommend that N1 patients should receive regional nodal irradiation for a large tumor burden (e.g., three positive nodes, perinodal extension, or large primary tumor). Finally, the panels favored OFS in addition to endocrine therapy for premenopausal women with high risk factors such as a large tumor size, involvement of more than three nodes, and a high histologic grade.

AB - The Korean clinical practice guideline recently developed by the Korean Breast Cancer Society to address the national clinical situation is currently under revision ahead of a seventh recommendation. A second consensus conference was held to further develop this guideline by soliciting opinions regarding important issues related to surgery, radiotherapy, and medical oncology. Several issues were discussed, and the discussion progressed to pros and cons in the context of cases in various clinical situations. The panels discussed and voted on issues regarding surgical treatment for non-axillary regional lymph nodes, regional nodal irradiation of pN1 disease, and ovarian functional suppression (OFS) as an adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer. Regarding the surgical treatment of non-axillary regional lymph node, most panelists agreed with the recommendation of preoperative che- motherapy and postoperative radiotherapy for patients with biopsy-diagnosed metastases, whereas surgery or radiotherapy of non-axillary regional lymph nodes was suggested for clinical partial responders. Discussions on radiotherapy addressed the need for adjuvant radiotherapy and radiation field of regional lymph node in the context of various N1 breast cancer cases. The participants reached a consensus to recommend that N1 patients should receive regional nodal irradiation for a large tumor burden (e.g., three positive nodes, perinodal extension, or large primary tumor). Finally, the panels favored OFS in addition to endocrine therapy for premenopausal women with high risk factors such as a large tumor size, involvement of more than three nodes, and a high histologic grade.

UR - http://www.scopus.com/inward/record.url?scp=85030653973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030653973&partnerID=8YFLogxK

U2 - 10.4048/jbc.2017.20.3.228

DO - 10.4048/jbc.2017.20.3.228

M3 - Article

AN - SCOPUS:85030653973

VL - 20

SP - 228

EP - 233

JO - Journal of Breast Cancer

JF - Journal of Breast Cancer

SN - 1738-6756

IS - 3

ER -